Difference between revisions of "HAEM5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[unchecked revision] | [unchecked revision] |
Line 725: | Line 725: | ||
| || | | || | ||
|- | |- | ||
− | |CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)|| || | + | |CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)|| || || || || || || || |
− | |||
| || | | || | ||
|- | |- | ||
− | |CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES)|| || | + | |CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES)|| || || || || || || || |
− | |||
| || | | || | ||
|- | |- | ||
− | |CHAPTER 7 (GENETIC TUMOUR SYNDROMES)|| || | + | |CHAPTER 7 (GENETIC TUMOUR SYNDROMES)|| || || || || || || || |
− | |||
| || | | || | ||
|- | |- |
Revision as of 13:33, 17 December 2023
Disease (5th Edition) | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Correlated Prior Disease Name (4th Edition) | Notes |
---|---|---|---|---|---|---|---|---|---|---|
CHAPTER 2 (MYELOID PROLIFERATIONS AND NEOPLASMS) |
|
|
||||||||
Clonal haematopoiesis | Disease | Fabiola Quintero-Rivera (FQR) | ||||||||
Clonal cytopenias of undetermined significance | Disease | FQR | ||||||||
Chronic myeloid leukaemia | Disease | Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) | FQR | |||||||
Chronic neutrophilic leukaemia | Disease | Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine **contributed equally | FQR | |||||||
Chronic eosinophilic leukaemia | Disease | Chelsea D. Kramish; Daynna J.Wolff Pending Review* | FQR | |||||||
Polycythaemia vera | Disease | Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center | FQR | |||||||
Essential thrombocythaemia | Disease | Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN | FQR | |||||||
Primary myelofibrosis | Disease | T. Niroshi Senaratne, UCLA | FQR | |||||||
Juvenile myelomonocytic leukaemia | Disease | Assistant Professor, Pathology Associate Director | Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories | FQR | |||||||
Myeloproliferative neoplasm, NOS | Disease | Thomas Lee, MD, PhD, University of California, Los Angeles | FQR | |||||||
Cutaneous mastocytosis | Disease | S. Shawn Liu, MD, PhD and Thuy Phung, MD, PhD | FQR | |||||||
Systemic mastocytosis | Disease | Abdullah Osme, MD, University Hospitals Cleveland Medical Center, Case Western Reserve University Shashi Shetty, Ph.D. FACMG, FCCMG, University Hospitals Cleveland Medical Center, Case Western Reserve University | FQR | |||||||
Mast cell sarcoma | Disease | Jordan Lowery, MD and Thuy Phung, MD, PhD Department of Pathology, University of South Alabama, Mobile, AL | FQR | |||||||
Myelodysplastic neoplasm with low blasts and 5q deletion | Disease | FQR | ||||||||
Myelodysplastic neoplasm with low blasts and SF3B1 mutation | Disease | FQR | ||||||||
Myelodysplastic neoplasm with biallelic TP53 inactivation | Disease | FQR | ||||||||
Myelodysplastic neoplasm with low blasts | Disease | FQR | ||||||||
Myelodysplastic neoplasm, hypoplastic | Disease | FQR | ||||||||
Myelodysplastic neoplasm with increased blasts | Disease | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. | FQR | |||||||
Childhood myelodysplastic neoplasm with low blasts | Disease | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. | FQR | |||||||
Childhood myelodysplastic neoplasm with increased blasts | Disease | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. | FQR | |||||||
Chronic myelomonocytic leukaemia | Disease | Linsheng Zhang, MD, PhD | FQR | |||||||
Myelodysplastic/myeloproliferative neoplasm with neutrophilia | Disease | Linsheng Zhang, MD, PhD | FQR | |||||||
Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis | Disease | Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine | FQR | |||||||
Myelodysplastic/myeloproliferative neoplasm, NOS | Disease | Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia | FQR | |||||||
Myeloid/lymphoid neoplasm with PDGFRA rearrangement | Disease | Jay Alden, DO | FQR | |||||||
Myeloid/lymphoid neoplasm with PDGFRB rearrangement | Disease | Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD | FQR | |||||||
Myeloid/lymphoid neoplasm with FGFR1 rearrangement | Disease | Yanna Ding, MD PhD | FQR | |||||||
Myeloid/lymphoid neoplasm with JAK2 rearrangement | Disease | Jessica Snider, M.D. and Daynna J. Wolff, PhD | FQR | |||||||
Myeloid/lymphoid neoplasm with FLT3 rearrangement | Disease | FQR | ||||||||
Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion | Disease | FQR | ||||||||
Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes | Disease | FQR | ||||||||
Acute promyelocytic leukaemia with PML::RARA fusion | Disease | Yiming Zhong, Ph.D., Megan Piazza, Ph.D., and Shashi Shetty, Ph.D. | Jennelle Hodge (JH)/ Malini Sathanoori (MS) | |||||||
Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion | Disease | Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA |
JH_MS | |||||||
Acute myeloid leukaemia with CBFB::MYH11 fusion | Disease | Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA |
JH_MS | |||||||
Acute myeloid leukaemia with DEK::NUP214 fusion | Disease | JH_MS | ||||||||
Acute myeloid leukaemia with RBM15::MRTFA fusion | Disease | Jennelle C. Hodge, PhD, FACMG | JH_MS | |||||||
Acute myeloid leukaemia with BCR::ABL1 fusion | Disease | Kay Weng Choy MBBS, Monash Medical Centre | JH_MS | |||||||
Acute myeloid leukaemia with KMT2A rearrangement | Disease | Megan Piazza, Ph.D., Yiming Zhong, Ph.D., Shashi Shetty, Ph.D. | JH_MS | |||||||
Acute myeloid leukaemia with MECOM rearrangement | Disease | JH_MS | ||||||||
Acute myeloid leukaemia with NUP98 rearrangement | Disease | JH_MS | ||||||||
Acute myeloid leukaemia with NPM1 mutation | Disease | Xinjie Xu, PhD, FACMG | JH_MS | |||||||
Acute myeloid leukaemia with CEBPA mutation | Disease | Paul Defazio, MSc, Monash Health | JH_MS | |||||||
Acute myeloid leukaemia, myelodysplasia-related | Disease | Fei Yang, MD, FACMG Oregon Health & Science University, Portland, OR |
JH_MS | |||||||
Acute myeloid leukaemia with other defined genetic alterations | Disease | JH_MS | ||||||||
Acute myeloid leukaemia with minimal differentiation | Disease | Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine | JH_MS | |||||||
Acute myeloid leukaemia without maturation | Disease | Jennelle C. Hodge, PhD, FACMG | JH_MS | |||||||
Acute myeloid leukaemia with maturation | Disease | Jennelle C. Hodge, PhD, FACMG | JH_MS | |||||||
Acute basophilic leukaemia | Disease | Ashwini Yenamandra PhD FACMG | JH_MS | |||||||
Acute myelomonocytic leukaemia | Disease | Fei Yang, MD, FACMG Oregon Health & Science University, Portland, OR |
JH_MS | |||||||
Acute monocytic leukaemia | Disease | Fei Yang, MD, FACMG Oregon Health & Science University, Portland, OR |
JH_MS | |||||||
Acute erythroid leukaemia | Disease | Ashwini Yenamandra PhD FACMG | JH_MS | |||||||
Acute megakaryoblastic leukaemia | Disease | Fei Yang, MD, FACMG Oregon Health & Science University, Portland, OR |
JH_MS | |||||||
Myeloid sarcoma | Disease | Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine | JH_MS | |||||||
Myeloid neoplasm post cytotoxic therapy | Disease | Shawn A. Silver, DO, Shashi Shetty, Ph.D. | JH_MS | |||||||
Myeloid neoplasms associated with germline predisposition | Disease | JH_MS | ||||||||
Myeloid proliferations associated with Down syndrome | Disease | Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO | JH_MS | |||||||
Mixed-phenotype acute leukaemia with BCR::ABL1 fusion | Disease | Tracy Tucker, PhD, FCCMG | JH_MS | |||||||
Mixed-phenotype acute leukaemia with KMT2A rearrangement | Disease | Tracy Tucker, PhD, FCCMG | JH_MS | |||||||
Acute leukaemia of ambiguous lineage with other defined genetic alterations | Disease | JH_MS | ||||||||
Mixed-phenotype acute leukaemia, B/myeloid | Disease | Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD | JH_MS | |||||||
Mixed-phenotype acute leukaemia, T/myeloid | Disease | Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine | JH_MS | |||||||
Mixed-phenotype acute leukaemia, rare types | Disease | Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | JH_MS | |||||||
Acute leukaemia of ambiguous lineage, NOS | Disease | JH_MS | ||||||||
Acute undifferentiated leukaemia | Disease | Amelia Nakanishi, MD and Shashi Shetty, PhD | JH_MS | |||||||
CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS) |
|
|
||||||||
Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm | Disease | Greg Corboy (GC) | ||||||||
Blastic plasmacytoid dendritic cell neoplasm | Disease | Hao Liu, MD and Daynna J. Wolff, PhD | GC | |||||||
Langerhans cell histiocytosis | Disease | Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | GC | |||||||
Langerhans cell sarcoma | Disease | Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | GC | |||||||
Indeterminate dendritic cell tumour | Disease | GC | ||||||||
Interdigitating dendritic cell sarcoma | Disease | GC | ||||||||
Juvenile xanthogranuloma | Disease | GC | ||||||||
Erdheim-Chester disease | Disease | GC | ||||||||
Rosai-Dorfman Disease | Disease | GC | ||||||||
ALK-positive histiocytosis | Disease | GC | ||||||||
Histiocytic sarcoma | Disease | Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic | GC | |||||||
CHAPTER 4 (B-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) |
|
|
||||||||
CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) | ||||||||||
CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES) | ||||||||||
CHAPTER 7 (GENETIC TUMOUR SYNDROMES) | ||||||||||
Reactive B-cell rich lymphoid proliferations that can mimic lymphoma | Disease | GC | ||||||||
IgG4-related disease | Disease | GC | ||||||||
Unicentric Castleman disease | Disease | GC | ||||||||
Idiopathic multicentric Castleman disease | Disease | GC | ||||||||
KSHV/HHV8-associated multicentric Castleman disease | Disease | Sudha Arumugam, MD | GC | |||||||
Diffuse large B-cell lymphoma, NOS | Disease | Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center | GC | |||||||
T-cell/histiocyte-rich large B-cell lymphoma | Disease | GC | ||||||||
Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements | Disease | Kate Berry, MBBS, BBus (Hons), Pathology Queensland | GC | |||||||
ALK-positive large B-cell lymphoma | Disease | Manando Nakasaki, MD, PhD (University of California, Irvine) Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine) | GC | |||||||
Large B-cell lymphoma with IRF4 rearrangement | Disease | *Afia Hasnain, MBBS, PhD | GC | |||||||
High grade B-cell lymphoma with 11q aberrations | Disease | Lauren Shealy, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | GC | |||||||
Lymphomatoid granulomatosis | Disease | GC | ||||||||
EBV-positive diffuse large B-cell lymphoma | Disease | GC | ||||||||
Diffuse large B-cell lymphoma associated with chronic inflammation | Disease | GC | ||||||||
Fibrin-associated large B-cell lymphoma | Disease | GC | ||||||||
Fluid overload-associated large B-cell lymphoma | Disease | GC | ||||||||
Plasmablastic lymphoma | Disease | Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) | GC | |||||||
Primary large B-cell lymphoma of immune-privileged sites | Disease | Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center | GC | |||||||
Primary cutaneous diffuse large B-cell lymphoma, leg type | Disease | GC | ||||||||
Intravascular large B-cell lymphoma | Disease | Kate Berry, MBBS, BBus (Hons), Pathology Queensland | GC | |||||||
Primary mediastinal large B-cell lymphoma | Disease | GC | ||||||||
Mediastinal grey zone lymphoma | Disease | GC | ||||||||
High-grade B-cell lymphoma, NOS | Disease | Aiko Otsubo, PhD, Indiana University | GC | |||||||
Burkitt lymphoma | Disease | Becky Leung, MBBS (Hons), BSc, Pathology Queensland | GC | |||||||
Primary effusion lymphoma | Disease | GC | ||||||||
KSHV/HHV8-positive diffuse large B-cell lymphoma | Disease | GC | ||||||||
KSHV/HHV8-positive germinotropic lymphoproliferative disorder | Disease | GC | ||||||||
Hyperplasias arising in immune deficiency/dysregulation | Disease | GC | ||||||||
Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation | Disease | Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI) | GC | |||||||
EBV-positive mucocutaneous ulcer | Disease | GC | ||||||||
Lymphomas arising in immune deficiency / dysregulation | Disease | GC | ||||||||
Inborn error of immunity-associated lymphoid proliferations and lymphomas | Disease | GC | ||||||||
Classic Hodgkin lymphoma | Disease | Patricia V. Hernandez, M.D., Washington University School of Medicine | GC | |||||||
Nodular lymphocyte predominant Hodgkin lymphoma | Disease | GC | ||||||||
Monoclonal B-cell lymphocytosis | Disease | SP | ||||||||
Chronic lymphocytic leukaemia/small lymphocytic lymphoma | Disease | Jamie Nagy, PhD, University of Iowa Honey Reddi, PhD | SP | |||||||
Hairy cell leukaemia | Disease | *Snehal Patel, MD, PhD | SP | |||||||
Splenic marginal zone lymphoma | Disease | *Snehal Patel, MD, PhD | SP | |||||||
Splenic diffuse red pulp small B-cell lymphoma | Disease | *Snehal Patel, MD, PhD | SP | |||||||
Splenic B-cell lymphoma/leukaemia with prominent nucleoli | Disease | *Snehal Patel, MD, PhD | SP | |||||||
Lymphoplasmacytic lymphoma | Disease | Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI) | SP | |||||||
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue | Disease | SP | ||||||||
Primary cutaneous marginal zone lymphoma | Disease | SP | ||||||||
Nodal marginal zone lymphoma | Disease | Andrew Ly, DO and Shivani Golem, PhD, FACMG | SP | |||||||
Paediatric nodal marginal zone lymphoma | Disease | * Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD | SP | |||||||
In situ follicular B-cell neoplasm | Disease | Rachel D. Burnside, PhD, MBA, FACMGG | SP | |||||||
Follicular lymphoma | Disease | Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida | SP | |||||||
Paediatric-type follicular lymphoma | Disease | *Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG | SP | |||||||
Duodenal-type follicular lymphoma | Disease | SP | ||||||||
Primary cutaneous follicle centre lymphoma | Disease | Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG | SP | |||||||
In situ mantle cell neoplasm | Disease | Rina Kansal, MD; Versiti Blood Center of Wisconsin | SP | |||||||
Mantle cell lymphoma | Disease | * Mahsa Khanlari, MD * Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | SP | |||||||
Leukaemic non-nodal mantle cell lymphoma | Disease | SP | ||||||||
Transformations of indolent B-cell lymphomas | Disease | SP | ||||||||
Cold agglutinin disease | Disease | SP | ||||||||
IgM monoclonal gammopathy of undetermined significance | Disease | SP | ||||||||
Non-IgM monoclonal gammopathy of undetermined significance | Disease | SP | ||||||||
Monoclonal gammopathy of renal significance | Disease | SP | ||||||||
Immunoglobulin-related (AL) amyloidosis | Disease | Heather E. Williams, PhD, MS, PgD, ErCLG | SP | |||||||
Monoclonal immunoglobulin deposition disease | Disease | Chen Yang, MD, PhD, University of Michigan | SP | |||||||
Mu heavy chain disease | Disease | SP | ||||||||
Gamma heavy chain disease | Disease | Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA | SP | |||||||
Alpha heavy chain disease | Disease | SP | ||||||||
Plasmacytoma | Disease | SP | ||||||||
Plasma cell myeloma / multiple myeloma | Disease | *Huan Mo, MD, MS *Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | SP | |||||||
Plasma cell neoplasms with associated paraneoplastic syndrome | Disease | Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD | SP | |||||||
Kikuchi-Fujimoto disease | Disease | SP | ||||||||
Autoimmune lymphoproliferative syndrome | Disease | SP | ||||||||
Indolent T-lymphoblastic proliferation | Disease | SP | ||||||||
T-prolymphocytic leukaemia | Disease | SP | ||||||||
T-large granular lymphocytic leukaemia | Disease | *Michelle Don, MD, MS | SP | |||||||
NK-large granular lymphocytic leukaemia | Disease | Michelle Don, MD | SP | |||||||
Adult T-cell leukaemia/lymphoma | Disease | Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center | SP | |||||||
Sezary syndrome | Disease | Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina | SP | |||||||
Aggressive NK-cell leukaemia | Disease | Shanelle De Lancy, MD, Shashirekha Shetty, PhD | SP | |||||||
Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder | Disease | SP | ||||||||
Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder | Disease | SP | ||||||||
Mycosis fungoides | Disease | Jane Scribner, MD and Daynna J. Wolff, PhD | SP | |||||||
Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis | Disease | SP | ||||||||
Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma | Disease | Theresa Spivey, MD, Shashirekha Shetty, PhD | SP | |||||||
Subcutaneous panniculitis-like T-cell lymphoma | Disease | SP | ||||||||
Primary cutaneous gamma/delta T-cell lymphoma | Disease | SP | ||||||||
Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma | Disease | SP | ||||||||
Primary cutaneous peripheral T-cell lymphoma, NOS | Disease | SP | ||||||||
Indolent T-cell lymphoma of the gastrointestinal tract | Disease | Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | SP | |||||||
Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract | Disease | SP | ||||||||
Enteropathy-associated T-cell lymphoma | Disease | *Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD | SP | |||||||
Monomorphic epitheliotropic intestinal T-cell lymphoma | Disease | Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | SP | |||||||
Intestinal T-cell lymphoma, NOS | Disease | Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA) | SP | |||||||
Hepatosplenic T-cell lymphoma | Disease | *Michelle Don, MD, MS | SP | |||||||
ALK-positive anaplastic large cell lymphoma | Disease | SP | ||||||||
ALK-negative anaplastic large cell lymphoma | Disease | Miguel Gonzalez Mancera, MD Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA | SP | |||||||
Breast implant-associated anaplastic large cell lymphoma | Disease | Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center | SP | |||||||
Nodal TFH cell lymphoma, angioimmunoblastic-type | Disease | * Sara Akhavanfard, M.D., Ph.D. * Ruthann Pfau, Ph.D., FACMG | SP | |||||||
Nodal TFH cell lymphoma, follicular-type | Disease | SP | ||||||||
Nodal TFH cell lymphoma, NOS | Disease | Hans Magne Hamnvåg, MD Kamran Mirza, MD, PhD | SP | |||||||
Peripheral T-cell lymphoma, NOS | Disease | SP | ||||||||
EBV-positive nodal T- and NK-cell lymphoma | Disease | SP | ||||||||
Extranodal NK/T-cell lymphoma | Disease | SP | ||||||||
Severe mosquito bite allergy | Disease | SP | ||||||||
Hydroa vacciniforme lymphoproliferative disorder | Disease | SP | ||||||||
Systemic chronic active EBV disease | Disease | SP | ||||||||
Systemic EBV-positive T-cell lymphoma of childhood | Disease | *Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA | SP | |||||||
Follicular dendritic cell sarcoma | Disease | Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG | SP | |||||||
EBV-positive inflammatory follicular dendritic cell sarcoma | Disease | SP | ||||||||
Fibroblastic reticular cell tumour | Disease | SP | ||||||||
Intranodal palisaded myofibroblastoma | Disease | SP | ||||||||
Littoral cell angioma | Disease | SP | ||||||||
Splenic hamartoma | Disease | SP | ||||||||
Sclerosing angiomatoid nodular transformation (SANT) of spleen | Disease | SP | ||||||||
B-lymphoblastic leukaemia/lymphoma | Disease | YA | ||||||||
B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy | Disease | Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG | YA | |||||||
B-lymphoblastic leukaemia/lymphoma with hypodiploidy | Disease | Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG | YA | |||||||
B-lymphoblastic leukaemia/lymphoma with iAMP21 | Disease | Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte | YA | |||||||
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion | Disease | Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG | YA | |||||||
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features | Disease | Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine | YA | |||||||
B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement | Disease | Yassmine Akkari Nicolas Millan | YA | |||||||
B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion | Disease | Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma | YA | |||||||
B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features | Disease | YA | ||||||||
B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion | Disease | Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO | YA | |||||||
B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion | Disease | Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO | YA | |||||||
B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion | Disease | YA | ||||||||
B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations | Disease | YA | ||||||||
B-lymphoblastic leukaemia/lymphoma, NOS | Disease | YA | ||||||||
T-lymphoblastic leukaemia / lymphoma, NOS | Disease | YA | ||||||||
Early T-precursor lymphoblastic leukaemia / lymphoma | Disease | Fei Yang, MD, FACMG, Kaiser Permanente Northwest | YA | |||||||
Fanconi anaemia | Disease | NA | ||||||||
Bloom syndrome | Disease | NA | ||||||||
Ataxia-telangiectasia syndrome | Disease | NA | ||||||||
RASopathies | Disease | NA |